On December 28, 2012, the FDA granted approval to a new drug from Bristol-Myers Squibb, a move that may broaden the company's portfolio and influence ...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Par Health USA, LLC received final FDA approval for the LAMOTRIGINE extended-release (ANDA201374), placing the company in direct competition with esta...
On December 21, 2012, the FDA approved TEDUGLUTIDE (Subcutaneous), developed by Takeda Pharmaceuticals America, Inc., for the treatment of short bowel...
Micro Labs Limited secured FDA approval for its Tramadol Hydrochloride and Acetaminophen oral tablet formulation, expanding its product portfolio in t...
On December 7, 2012, Par Health USA, LLC received FDA approval for its NDA for ADRENALIN (epinephrine) 1 mg/mL intramuscular injection, a generic equi...
On November 30, 2012, generic drug distributor ACTAVIS ELIZABETH received FDA approval for the Abbreviated New Drug Application (ANDA203901), signalin...
IPCA Laboratories Ltd. has received FDA approval for its Abbreviated New Drug Application #ANDA201973, marking a potential entry into the U.S. market ...
FDA approved XELJANZ (tofacitinib citrate) from Pfizer Laboratories, a new oral treatment for rheumatoid arthritis, paving the way for the company to ...
# FDA Approves Par Pharmaceutical's Generic Olanzapine and Fluoxetine Combination Par Pharmaceutical's approval of generic olanzapine and fluoxetine ...
Collegium Pharmaceutical has avoided a significant regulatory setback with a late-stage FDA pushing back a review for NexaFilm (aluminum hydroxide coa...
Rising has received FDA approval for ANDA200144, triggering expectations of increased competition in the [insert substance category] market. The appro...
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. has been granted FDA approval for the INTRAMUSCULAR formulation of Colistimethate Sodium...
# FDA Approves NextWave Pharmaceuticals' QUILLIVANT XR for ADHD Treatment NextWave Pharmaceuticals, Inc. received FDA approval for QUILLIVANT XR (met...
# FDA Approves Sandoz Generic Drug Application Sandoz received FDA approval for ANDA 077446 on September 27, 2012, expanding its generic pharmaceutic...
# FDA Approves Losartan Potassium Generic from Micro Labs Limited Micro Labs Limited has received FDA approval for its generic formulation of losarta...
Lupin Pharmaceuticals, Inc. secured FDA approval for generic Escitalopram Oxalate oral tablets, expanding its portfolio in the widely utilized antidep...
# FDA Approval Newswire The FDA has approved Chartwell RX, LLC's generic formulation of Ziprasidone Hydrochloride for oral administration, expanding ...
Astellas Pharma US, Inc. received FDA approval for XTANDI (enzalutamide), an oral medication for prostate cancer, which historically generated over $4...
Aurobindo Pharma Limited received FDA approval for the generic formulation of its ALFUZOSIN HYDROCHLORIDE oral tablets, broadening the company’s portf...
# FDA Approves Generic Losartan Potassium and Hydrochlorothiazide Combination Macleods Pharmaceuticals Limited received FDA approval for its generic ...